News
Oxford University launches Covid-19 vaccine study in children
The University of Oxford has launched the first study of ChAdOx1 nCoV-19 Covid-19 vaccine in children and young adults.
The single-blind, randomised phase II trial,...
News
BioIVT Unveils COVID-19 Panel to Accelerate Vaccine-generated Immune Response Research
BioIVT, a leading provider of research models and services for drug and diagnostic development, introduced its COVID-19 Vaccination Panel, composed of pre- and post-vaccination...
News
Biocon Biologics Joins Hands with IDF in its Mission to Promote Diabetes Care, Prevention and effective Management Worldwide
Biocon Biologics Ltd., a fully integrated ‘pure play’ biosimilars company and a subsidiary of Biocon Ltd., is pleased to partner with The International Diabetes...
Press Releases
AstraZeneca COVID-19 vaccine authorised for emergency use by the World Health Organization
AstraZeneca’s COVID-19 vaccine has been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) for active immunisation to prevent COVID-19 in individuals...
News
Pfizer Is The First Covid-19 Vaccine to be Approved in Japan
Japan’s Health Ministry has approved Pfizer’s Covid-19 vaccine as the Summer Olympic Games begin in July.
The approval marks the first in the country as...
News
Four potential Covid-19 therapeutics enter phase 2/3 testing in NIH ACTIV-2 trial
Enrollment has begun to test additional investigational drugs in the Accelerating Covid-19 Therapeutic Interventions and Vaccines (ACTIV) programme.
ACTIV is a public-private partnership programme to...
News
CureVac Initiates Rolling Submission With European Medicines Agency for COVID-19 Vaccine Candidate, CVnCoV
CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), announced initiation of a rolling...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read